Doctor profile · Federal record
Dr. Caitlin Onorato, APRN
Nurse Practitioner · Lecanto, FL
- NPI 1316511728
- Accepts Medicare
- MIPS 81.3 / 100 · 2023
- 5 yrs in practice
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
525 N Dacie PT
Lecanto, FL 344618399
(352) 746-2200 - Mailing address
-
4651 van Dyke RD
Lutz, FL 335584880
Credentials & registration
- NPI registered
- May 2021 — 5 yrs on file
- Profile last updated
- November 12, 2022
- Year of graduation
- 2021 — 5 yrs since
- Specialty taxonomy
- 363L00000X — NUCC code
- State license (1)
- Florida #11013054
- Medicaid
- FL #113627600
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1316511728. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,177
Distinct HCPCS
10
Medicare allowed
$104,945
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 770 | 133 | $5 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 422 | 315 | $75 | |
11102 |
Biopsy of related skin growth, first growth | 278 | 248 | $76 | |
17000 |
Destruction of precancer skin growth, 1 growth | 216 | 189 | $40 | |
11103 |
Biopsy of related skin growth, each additional growth | 123 | 86 | $41 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 110 | 110 | $94 | |
17110 |
Destruction of skin growth, 1-14 growths | 79 | 70 | $90 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 43 | 40 | $47 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 31 | 30 | $140 | |
77401 |
Superficial and/or low voltage radiation treatment delivery | 28 | 18 | $39 |
In context: peer comparison
Among 2 peers in Lecanto Nurse Practitioner, average services per provider: 133. This provider delivers 16× the peer median.Open Payments
Industry payments received
All-time total
$1,335
Transactions
45
Manufacturers
14
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, INC. | 5 | $273.27 | |
| Kerecis Limited | 3 | $252.03 | |
| Ucb, INC. | 4 | $162.71 | |
| Abbvie INC. | 11 | $156.03 | |
| Regeneron Healthcare Solutions, INC. | 6 | $138.17 | |
| Genzyme Corporation | 3 | $73.12 | |
| Amgen INC. | 3 | $71.12 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $48.50 | |
| Novartis Pharmaceuticals Corporation | 2 | $46.15 | |
| Biofrontera INC. | 2 | $43.76 | |
| Lilly USA, LLC | 1 | $22.59 | |
| Teva Pharmaceuticals USA, INC. | 1 | $16.87 | |
| Leo Pharma INC. | 1 | $16.69 | |
| Sun Pharmaceutical Industries INC. | 1 | $14.00 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,463
Patients
1,186
Total drug cost
$139,111
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Cephalexin | Generic | 695 | 611 | $3,035 |
| Doxycycline Hyclate | Generic | 173 | 149 | $2,790 |
| Triamcinolone Acetonide | Generic | 138 | 103 | $927 |
| Mupirocin | Generic | 130 | 102 | $1,090 |
| Clobetasol Propionate | Generic | 59 | 32 | $2,353 |
| Ketoconazole | Generic | 45 | 27 | $817 |
| Fluorouracil | Generic | 37 | 32 | $3,676 |
| Clindamycin Phosphate | Generic | 29 | 19 | $925 |
| Hydrocortisone | Generic | 29 | 26 | $149 |
| Ciclopirox (Ciclopirox Olamine) | Brand | 28 | 21 | $1,214 |
Frequently asked questions
What is Dr. Caitlin Onorato's medical specialty?
Dr. Caitlin Onorato practices Nurse Practitioner in Lecanto, FL.
Where does Dr. Caitlin Onorato practice?
Dr. Caitlin Onorato practices at 525 N Dacie PT, Lecanto, FL 344618399. Office phone: 3527462200.
What is Dr. Caitlin Onorato's NPI?
Dr. Caitlin Onorato's National Provider Identifier (NPI) is 1316511728, issued by NPPES.
Does Dr. Caitlin Onorato accept Medicare assignment?
Yes. Dr. Caitlin Onorato accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Caitlin Onorato commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Biopsy of related skin growth, first growth (HCPCS 11102). Source: CMS Medicare Physician & Other Practitioners file.